The CT HIV Planning Consortium (CHPC) is a collaborative body focused on addressing the HIV epidemic through coordinated efforts in prevention, care, and support across the state of Connecticut. Comprised of community members, healthcare providers, and public health officials, the consortium meets monthly to ensure that voices from diverse communities are represented in decision-making processes. CHPC aims to improve health outcomes and reduce disparities by promoting innovative strategies, resource sharing, education, and advocacy.

This month will feature the presentation, Status Neutral: Long-Acting Injectables for HIV Treatment and PrEP presented by Dr. Onyema Ogbuagu from Yale University's School of Medicine.

The presentation's objectives include:

• Increase knowledge on Lenacapivir's use as HIV PrEP
• Review long-acting injectables' use as HIV treatment

All sessions provided in the CT Statewide Grand Round Series are CME-accredited. For more information, please reach out Dante Gennaro, Program Director of the NEAETC's Connecticut Local Partner site at Yale University.

Intended Audience

Attendees of the CHPC and any member of the public.

Contact